InterventionsHumans27 subjectsCohort study

SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure

Journal of Molecular and Cellular Cardiology Plus

The paper

Cinkajzlova A, Kasperova BJ, Ivak P et al.

Journal of Molecular and Cellular Cardiology Plus · 16 Aug 2026

doi.org/10.1016/j.jmccpl.2026.100860 PubMed 42668568

Inflammatory burden is linked to incident heart failure
medRxiv · 4 Oct 2026
Astragaloside IV reduces cardiac aging in mice by restoring mitochondrial balance
FASEB Journal · 2 Oct 2026
Lack of the AT2R receptor accelerates cardiac senescence and fibrosis in aging mice
Clinical Science · 2 Oct 2026
CD47 blockade reduces doxorubicin-induced cardiac aging in male mice
Physiological Reports · 3 Oct 2026